Synexa Life Sciences

Biomarker and bioanalytical CRO

Synexa Life Sciences is a biomarker and bioanalytical contract research organisation (CRO). It specialises in developing, validating and delivering complex, custom-designed assays for clinical trial sample analysis.

Core capabilities

• Biomarker identification and development
• Large and small molecule clinical bioanalysis
• Soluble biomarker analysis using MSD, LC-MS/MS, ELISA, RIA, and fluorescence and luminescence-based technologies
• Cell biology, including flow cytometry, ELISpot and Fluorospot
• Genomic services to support clinical trials and translational studies
• Olink proteomics, immunogenicity, pharmacokinetic (PK) and toxicokinetic (TK) services, and pharmacodynamics
• Radiopharmaceutical bioanalysis, tissue imaging and dose formulation analysis

Operating model

The company describes its scientists as an extension of client teams. Its work is aimed at supporting clients from discovery through to regulatory submission. The site lists expertise in obesity and metabolic disease, autoimmune conditions, oncology, vaccines, biosimilars, ADCs and cell therapies.

Locations

The company operates laboratories in Manchester (UK), Turku (Finland) and Cape Town (South Africa).